The Point-of-Care Infectious Disease Diagnostics or Testing market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Point-of-Care Infectious Disease Diagnostics or Testing market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Point-of-Care Infectious Disease Diagnostics or Testing market.
Key players in the global Point-of-Care Infectious Disease Diagnostics or Testing market covered in Chapter 2 and Chapter 6:
Chembio Diagnostics Inc
Trivitron Healthcare
OJ-Bio Ltd.
Alere
Thermo Fisher Scientific Inc
Quest Diagnostics, Inc
Siemens Healthineers
Cardinal Health
bioM?rieux SA
Ortho-Clinical Diagnostic
Gene POC
F. Hoffmann-La Roche Ltd
Trinity Biotech
BD & Company
Bio-Rad Labs Inc.
Sight Diagnostics Ltd.
In Chapter 8 and Chapter 10.3, based on types, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2017 to 2029 is primarily split into:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Other infectious disease POC
In Chapter 9 and Chapter 10.4, based on applications, the Point-of-Care Infectious Disease Diagnostics or Testing market from 2017 to 2029 covers:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Point-of-Care Infectious Disease Diagnostics or Testing market, containing global revenue and CAGR. The forecast and analysis of Point-of-Care Infectious Disease Diagnostics or Testing market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Point-of-Care Infectious Disease Diagnostics or Testing. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Point-of-Care Infectious Disease Diagnostics or Testing industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Point-of-Care Infectious Disease Diagnostics or Testing industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Point-of-Care Infectious Disease Diagnostics or Testing in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Point-of-Care Infectious Disease Diagnostics or Testing market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Point-of-Care Infectious Disease Diagnostics or Testing, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Point-of-Care Infectious Disease Diagnostics or Testing market, including the global sales and revenue forecast, regional forecast. It also foresees the Point-of-Care Infectious Disease Diagnostics or Testing market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Point-of-Care Infectious Disease Diagnostics or Testing Market Overview
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics or Testing
1.2 Point-of-Care Infectious Disease Diagnostics or Testing Segment by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of HIV POC
1.2.3 The Market Profile of Clostridium difficile POC
1.2.4 The Market Profile of HBV POC
1.2.5 The Market Profile of Pneumonia or Streptococcus associated infections
1.2.6 The Market Profile of Respiratory syncytial virus (RSV) POC
1.2.7 The Market Profile of HPV POC
1.2.8 The Market Profile of Influenza/Flu POC
1.2.9 The Market Profile of HCV POC
1.2.10 The Market Profile of MRSA POC
1.2.11 The Market Profile of TB and drug-resistant TB POC
1.2.12 The Market Profile of HSV (Herpes Simplex Virus) POC
1.2.13 The Market Profile of Other infectious disease POC
1.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Segment by Application
1.3.1 Point-of-Care Infectious Disease Diagnostics or Testing Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Hospitals
1.3.3 The Market Profile of Clinics
1.3.4 The Market Profile of Home
1.3.5 The Market Profile of Assisted Living Healthcare Facilities
1.3.6 The Market Profile of Laboratories
1.3.7 The Market Profile of Others
1.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Market, Region Wise (2017-2022)
1.4.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3 Europe Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.1 Germany Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.2 UK Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.3 France Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.4 Italy Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.5 Spain Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.6 Russia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.3.7 Poland Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.4 China Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.5 Japan Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.6 India Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.8 Latin America Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Point-of-Care Infectious Disease Diagnostics or Testing Market Status and Prospect (2017-2022)
1.5 Global Market Size of Point-of-Care Infectious Disease Diagnostics or Testing (2017-2029)
1.5.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Revenue Status and Outlook (2017-2029)
1.5.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Sales Status and Outlook (2017-2029)
2 Global Point-of-Care Infectious Disease Diagnostics or Testing Market Landscape by Player
2.1 Global Point-of-Care Infectious Disease Diagnostics or Testing Sales and Share by Player (2017-2022)
2.2 Global Point-of-Care Infectious Disease Diagnostics or Testing Revenue and Market Share by Player (2017-2022)
2.3 Global Point-of-Care Infectious Disease Diagnostics or Testing Average Price by Player (2017-2022)
2.4 Global Point-of-Care Infectious Disease Diagnostics or Testing Gross Margin by Player (2017-2022)
2.5 Point-of-Care Infectious Disease Diagnostics or Testing Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Point-of-Care Infectious Disease Diagnostics or Testing Market Competitive Situation and Trends
2.6.1 Point-of-Care Infectious Disease Diagnostics or Testing Market Concentration Rate
2.6.2 Point-of-Care Infectious Disease Diagnostics or Testing Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Point-of-Care Infectious Disease Diagnostics or Testing Upstream and Downstream Analysis
3.1 Point-of-Care Infectious Disease Diagnostics or Testing Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Point-of-Care Infectious Disease Diagnostics or Testing Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Point-of-Care Infectious Disease Diagnostics or Testing Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Point-of-Care Infectious Disease Diagnostics or Testing Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Point-of-Care Infectious Disease Diagnostics or Testing
5.3.2 Increased Demand in Emerging Markets
5.4 Point-of-Care Infectious Disease Diagnostics or Testing Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Point-of-Care Infectious Disease Diagnostics or Testing Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Chembio Diagnostics Inc
6.1.1 Chembio Diagnostics Inc Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.1.3 Chembio Diagnostics Inc Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.1.4 Chembio Diagnostics Inc Business Overview
6.2 Trivitron Healthcare
6.2.1 Trivitron Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.2.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.2.4 Trivitron Healthcare Business Overview
6.3 OJ-Bio Ltd.
6.3.1 OJ-Bio Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.3.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.3.4 OJ-Bio Ltd. Business Overview
6.4 Alere
6.4.1 Alere Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.4.3 Alere Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.4.4 Alere Business Overview
6.5 Thermo Fisher Scientific Inc
6.5.1 Thermo Fisher Scientific Inc Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.5.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.5.4 Thermo Fisher Scientific Inc Business Overview
6.6 Quest Diagnostics, Inc
6.6.1 Quest Diagnostics, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.6.3 Quest Diagnostics, Inc Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.6.4 Quest Diagnostics, Inc Business Overview
6.7 Siemens Healthineers
6.7.1 Siemens Healthineers Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.7.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.7.4 Siemens Healthineers Business Overview
6.8 Cardinal Health
6.8.1 Cardinal Health Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Point-of-Care Infectious Disease Diagnostics or Testing Product Profiles, Application and Specification
6.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics or Testing Market Performance (2017-2022)
6.8.4 Cardinal Health Business Overview
6.9 bioM
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)